Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 31,004 | 76,015 | N/A | N/A |
| Marketable Securities | 265,198 | 15,942 | N/A | N/A |
| Receivables | 577 | N/A | N/A | N/A |
| Other current assets | 856 | 0 | 0 | 0 |
| TOTAL | $302,339 | $92,845 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 10,841 | 3,794 | N/A | N/A |
| Investments And Advances | 162,531 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,464 | 20,063 | 0 | 0 |
| TOTAL | $184,836 | $23,857 | $N/A | $N/A |
| Total Assets | $487,175 | $116,702 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 4,368 | 3,276 | 0 | 0 |
| Accrued Expenses | 10,330 | 4,568 | N/A | N/A |
| Other current liabilities | 106 | N/A | N/A | N/A |
| TOTAL | $110,617 | $34,570 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 92,552 | 23,349 | N/A | N/A |
| Other Non-Current Liabilities | 14,228 | 16,651 | 0 | 0 |
| TOTAL | $92,670 | $47,458 | $N/A | $N/A |
| Total Liabilities | $203,287 | $82,028 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 44,811 | N/A | N/A | N/A |
| Common Shares | 4 | N/A | N/A | N/A |
| Retained earnings | -128,765 | -76,456 | N/A | N/A |
| Other shareholders' equity | -128 | 109,086 | 0 | 0 |
| TOTAL | $283,888 | $34,674 | $N/A | $N/A |
| Total Liabilities And Equity | $487,175 | $116,702 | $0 | $0 |